Wednesday 5 October 2016

08:00

Registration and refreshments

09:00

Chairman’s opening remarks: Diva Duong, Vice President Compliance EMEA-APAC, IMS Health

Mr Dario Ghoddousi
09:05

Transparency landscape in Europe: Implementation of EFPIA in Pharma presented by Dario Ghoddousi, Vice President of Product Management, IMS Health

Session led by: ims-health
Mr Peter Herrmann
09:45

Accountability and risk of the compliance programme

Mr Peter Herrmann, Corporate Compliance Officer, Actelion
10:15

Speed networking

10:45

Morning refreshments

Panel discussion
11:15

How to establish a corporate compliant culture and implement an ethical business conduct

Mr Ian Storey, Senior Compliance Director, AstraZeneca
Mr Martin Fuerle, General Counsel & Chief Compliance Officer, Daiichi Sankyo Europe
Mr Peter Herrmann, Corporate Compliance Officer, Actelion
Ms Michaeline Daboul
12:00

New Standards for Enterprise Compliance Management presented by Michaeline Daboul, President and CEO, MMIS | MediSpend

Session led by: mmis-|-medispend
12:30

Lunch

Transparency and reporting
13:30

How to comply with EFPIA’s transparency code

Ms Marie Claire Pickaert, Deputy Director General, European Federation of Pharmaceutical Industries and Associations
Compliant marketing and sales
13:30

Understanding the new marketplace and compliance issues raised by changes

Ms Asli Kasabaligil, Head of Medical & Business Integrity, UCB Pharma
Transparency and reporting
14:00

Making the numbers talk! See what your spend data may be telling us?

Session led by: qordata
Compliant marketing and sales
14:10

Navigating the line between scientific exchange and promotion

Mrs Louise Vorborg, Quality and Compliance Officer, Pfizer Denmark
Transparency and reporting
14:30

Compliance policies and procedures

Mr Alexander Davison, Office of Ethics and Compliance Manager, AbbVie
Compliant marketing and sales
14:45

Optimising interaction between HCP and sales team

Ms Martina Heidelberger, Regional Compliance Manager, EEMEA, F. Hoffman-La Roche Ltd
Transparency and reporting
15:00

How to collect consent, report etc overcoming hurdles to be able to create the disclosure report?

Mrs Anna Byrom, Associate Director, Compliance EUCA, Intercept Pharma
Compliant marketing and sales
15:20

Engaging with medical societies and congress organisers

Ms Ursula Hohlneicher, Director of R and D Quality and Compliance, AstraZeneca
Transparency and reporting
15:30

Maintaining the disclosure reports and consent e.g. data is moving, consent withdrawals, disputes

Mr Laurence Scates, Transparency Programme Director, Astellas Pharma EMEA
16:00

Afternoon refreshments

16:30

Dissemination and exchange of scientific information – the line between promotion and scientific exchange

Ms Ursula Hohlneicher, Director of R and D Quality and Compliance, AstraZeneca
16:30

Managing consent to disclose and relationships with HCPs

Ms Martina Heidelberger, Regional Compliance Manager, EEMEA, F. Hoffman-La Roche Ltd
16:30

Overcoming issues in running a global compliance program

Mr Ian Storey, Senior Compliance Director, AstraZeneca
16:30

Peer to Peer Roundtables

16:30

Transparency

Mr Laurence Scates, Transparency Programme Director, Astellas Pharma EMEA
17:30

Closing Remarks and Networking

last published: 03/Oct/16 16:05 GMT
BOOK NOW